Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01844583
Title Safety, Tolerability and PK of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarasota Florida United States Details
Saint Louis Missouri United States Details
Oklahoma City Oklahoma United States Details
Nashville Tennessee United States Details
Dallas Texas United States Details
San Antonio Texas United States Details
Madison Wisconsin United States Details
*Shaded cells indicate that there was no data available from for the field